by Medicine by Design | Apr 22, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of proflies that feature “people” of Medicine by Design. Some minor edits...
by Medicine by Design | Apr 15, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of profiles that feature “people of Medicine by Design.” Some minor edits...
by Krystal Jacques | Apr 11, 2024
In current organoid technologies, human pluripotent stem cells are guided to differentiate into 3D structures that resemble the corresponding human in-vivo organ, which allows researchers the opportunity to study the organ’s specific cells and function. However,...
by Lyla El-Fayomi | Apr 4, 2024
Regenerative Medicine News Under the Microscope is back! Thank you all for your patience as I wrapped up my PhD; the hiatus is officially over. We’re celebrating the return of this feature with a double header covering regenerative medicine research highlights from...
by Stacey Johnson | Mar 29, 2024
Dr. Michel Sadelain, the “inventor of T cells” and a graduate of the University of Alberta, has won the 2024 Breakthrough Prize in life sciences. After completing his medical degree at the University of Paris, Dr. Sadelain earned his PhD in immunology at the...
by Stacey Johnson | Mar 22, 2024
Today is World Water Day, an observance that the United Nations has been recognizing since 1993. What does water have to do with regenerative medicine? Stick with me. (And no, I’m not going to talk about hydrogels.) World Water Day was established to raise awareness...
by Stacey Johnson | Mar 8, 2024
Today is International Women’s Day (IWD). If you are tired of hearing about the lack of gender equality in science, technology, engineering and mathematics (STEM), this post is not for you. If it makes you tired that in 2024 this remains an issue, read on. We all have...
by Laine Bodnar | Feb 29, 2024
In my role as a communication professional at CCRM, I have had the opportunity to attend industry conferences and events. There, I have met brilliant minds in the regenerative medicine and cell therapy field and learned about the work that’s happening in their...
by Stacey Johnson | Feb 23, 2024
As a fair-skinned, freckled person (my mom says she painted them on me while I slept), and one who has a family history of skin cancers and melanoma, the news on February 19 that Iovance Biotherapeutics’ AMTAGVITM received U.S. Food and Drug Administration (FDA)...
Comments